With a market-beating 3.5% yield, great range of new drugs and decent dividend growth since the recession, PFE stock has found its way into plenty of income-seekers portfolios. But the best is yet to come. Thanks to the new GOP tax …
And despite issuing better-than-predicted 2018 guidance, PFE stock fell as much as 2 percent in early morning trading. Heading into the earnings report, Pfizer shares were up 24 percent, matching the gains of the Standard & Poor's 500 …
(NYSE: AGN) announced the largest healthcare deal in history today (Monday). But despite the historic news, the PFE stock price was down 2.3% today. Allergan stock was down 3%. In a record-breaking $160 billion merger, the Pfizer …
Pharmaceutical giant Pfizer Inc. (NYSE: PFE) reported fourth-quarter earnings Tuesday morning, marginally exceeding earnings expectations and meeting expected revenue numbers. And despite issuing better-than-predicted 2018 …
Tara Clarke: Pfizer Inc. (NYSE:PFE) will soon feel the pressure from the wave of lawsuits being filed claiming that Pfizer’s blockbuster drug Lipitor – the world’s best-selling drug of all time – causes type-2 diabetes in women. With a market ...
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
24/7 Wall St. has generated a bullish and bearish scenario for 2014 in each stock of the Dow, including Pfizer Inc. (NYSE: PFE) and rival Merck & Co. (NYSE: MRK). Both of these pharmaceutical giants are defensive stocks by nature, yet …
PFE closed Tuesday's trading at $36.94 ... Under the terms of the agreement, Skyline Medical is purchasing preferred stock convertible into 20% of the outstanding common stock of Helomics, representing 20% of the company, in …
Pfizer Inc. (NYSE: PFE) today reported the top-line results of an international Phase III clinical trial which compared the combination of VFEND® (voriconazole) and ERAXISTM (anidulafungin) to VFEND monotherapy for primary therapy of …
Pfizer PFE is one of the largest pharmaceutical companies out there. With a market cap above $200 billion, many may think that the company doesn’t have much more room to grow its share price, but what’s not to love? The company has …